PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PT Kalbe Farma Tbk (KLBF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9944
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements and over-the-counter (OTC) drugs, energy drinks and other preventive products. Kalbe is also involved in marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceuticals products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, and South Africa. The company serves hospitals, pharmacies and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk (KLBF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kalbe Farma and Genexine Form Joint Venture 11
Licensing Agreements 12
Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12
Acquisition 13
Kalbe Farma Plans To Acquire Health Food Company For US$41.2 Million 13
PT Kalbe Farma Tbk – Key Competitors 14
PT Kalbe Farma Tbk – Key Employees 15
PT Kalbe Farma Tbk – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Feb 27, 2018: Kalbe Inaugurated Drugs Ingredients and Biological Products Factory 19
Government and Public Interest 21
May 03, 2018: Kalbe Supports Downstream-ing of Research in Indonesia 21
Other Significant Developments 23
Jan 18, 2017: Kalbe Develops Biosimilar Factory 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kalbe Farma and Genexine Form Joint Venture 11
Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12
Kalbe Farma Plans To Acquire Health Food Company For US$41.2 Million 13
PT Kalbe Farma Tbk, Key Competitors 14
PT Kalbe Farma Tbk, Key Employees 15
PT Kalbe Farma Tbk, Other Locations 16
PT Kalbe Farma Tbk, Subsidiaries 17
PT Kalbe Farma Tbk, Joint Venture 18

List of Figures
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Taiwan Sugar Corp:企業の戦略的SWOT分析
    Taiwan Sugar Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Tyson Fresh Meats Inc:企業の戦略・SWOT・財務情報
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Synthetic Rubber Corp (2104):企業の財務・戦略的SWOT分析
    China Synthetic Rubber Corp (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Waste Management Inc (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management Inc (WM) is a provider of waste management environmental services. The company has presence in the waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. Through its personal counseli …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yokogawa Electric Corp (6841):石油・ガス:M&Aディール及び事業提携情報
    Summary Yokogawa Electric Corp (Yokogawa) is an industrial automation company. It manufactures and supplies products and solutions in measurement, control, and information technologies fields. The company’s product offering include differential pressure/pressure transmitters, flow meters, and proces …
  • SSAB AB:企業のM&A・事業提携・投資動向
    SSAB AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SSAB AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Genting Malaysia Berhad:戦略・SWOT・企業財務分析
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務情報
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dukat dd (LURA-R-A):企業の財務・戦略的SWOT分析
    Dukat dd (LURA-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aptus Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aptus Health Inc (Aptus), formerly Physicians Interactive Inc, a subsidiary of Merck & Co Inc, is a technology company that provides healthcare digital marketing solutions. The company offers strategy, solution design, customer segmentation, advertising, actionable analytic, commercial, paym …
  • Philips Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Chugoku Marine Paints Ltd (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints Ltd (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tofas Turk Otomobil Fabrikasi A.S.:企業の戦略・SWOT・財務情報
    Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Fortum Corp (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆